Cartesian Therapeutics Inc (FRA:1S70)
€ 6.6 +0.15 (+2.33%) Market Cap: 203.52 Mil Enterprise Value: 109.65 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 27/100

Cartesian Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 2, 2026 / 04:50 PM GMT
Release Date Price: €6 (-7.69%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RNAC.OQ - Cartesian Therapeutics Inc
Cartesian Therapeutics Inc at TD Cowen Healthcare Conference
Mar 02, 2026 / 04:50PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, everyone. Tyler Van Buren here, senior biotech analyst at TD Cowan.

Thank you very much for joining us at TD Cowan's 46th annual healthcare conference. For next session we have a hybrid presentation and fireside chat style Q&A with Cartesian, and it's my pleasure to introduce Carsten Brunn, the President and CEO, and Milos Milkovic, the Chief Medical Officer. It's a privilege to have you both here with us. I'll go and hand it over to you, Carsten, to get started with the presentation.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot